CC
ALBO

Cannell & Co’s Albireo Pharma Inc ALBO Stock Holding History

Cannell & Co’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-458
Closed -$16K – 284
2015
Q1 		$16K Hold
458
– – ﹤0.01% 262
2014
Q4 		$18K Sell
458
-667
-59% -$29.3K ﹤0.01% 268
2014
Q3 		$56K Sell
1,125
-1,204
-52% -$69.2K ﹤0.01% 267
2014
Q2 		$151K Hold
2,329
– – ﹤0.01% 264
2014
Q1 		$191K Buy
+2,329
New +$212K 0.01% 264

Other funds holding ALBO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Cannell & Co's ALBO Position: Q2 2015 in Review

Cannell & Co sold out of Albireo Pharma Inc (ALBO) in Q2 2015, closing a stake of 458 shares — an estimated $16K sold.

Cannell & Co first reported a position in ALBO in Q1 2014 and held it in 5 quarters. The position peaked at $191K in Q1 2014. 46 funds tracked by Wall St. Rank hold ALBO as of Q2 2015.

  • Cannell & Co reported no remaining Albireo Pharma Inc position as of Q2 2015 after selling out during the quarter.
  • Cannell & Co sold 458 Albireo Pharma Inc shares in Q2 2015, an estimated $16K.
  • Cannell & Co first reported a position in Albireo Pharma Inc in Q1 2014 and held it in 5 quarters.
  • Cannell & Co's Albireo Pharma Inc position peaked at $191K in Q1 2014.
  • 46 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q2 2015.

Based on Cannell & Co's 13F filing for Q2 2015, filed 13 Aug 2015.